The new labeling for the patch will include information about the higher levels of estrogen.The Ortho Evra contraceptive patch, produced by Ortho McNeil Pharmaceuticals, a unit of Johnson & Johnson ...
Viatris Inc. (NASDAQ:VTRS) on Thursday, released data from Phase 3 study evaluating the contraceptive efficacy and safety of XULANE LO low dose weekly dermal patch of 150 mcg norelgestromin and 17.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results